The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prospective screening for human epidermal growth factor receptor 2 (HER2) positivity in patients with inoperable locally advanced or metastatic gastric or gastro-esophageal junction cancer. AGMT gastric-5.
Ewald Woell
No relevant relationships to disclose
Peter Regitnig
No relevant relationships to disclose
Wolfgang Eisterer
No relevant relationships to disclose
Josef Thaler
No relevant relationships to disclose
Johnnes Gaenzer
No relevant relationships to disclose
Alois Wuestner
No relevant relationships to disclose
Alois Lang
No relevant relationships to disclose
Johannes Andel
No relevant relationships to disclose
Michael A. Fridrik
No relevant relationships to disclose
Richard Greil
No relevant relationships to disclose